- AustraliaNorth AmericaWorld
Investing News NetworkYour trusted source for investing success
Silver47 Exploration
Purpose Bitcoin ETF
Black Swan Graphene
Fidelity Advantage Bitcoin ETF
- Lithium Outlook
- Oil and Gas Outlook
- Gold Outlook Report
- Uranium Outlook
- Rare Earths Outlook
- All Outlook Reports
- Top Generative AI Stocks
- Top EV Stocks
- Biggest AI Companies
- Biggest Blockchain Stocks
- Biggest Cryptocurrency-mining Stocks
- Biggest Cybersecurity Companies
- Biggest Robotics Companies
- Biggest Social Media Companies
- Biggest Technology ETFs
- Artificial Intellgience ETFs
- Robotics ETFs
- Canadian Cryptocurrency ETFs
- Artificial Intelligence Outlook
- EV Outlook
- Cleantech Outlook
- Crypto Outlook
- Tech Outlook
- All Market Outlook Reports
- Cannabis Weekly Round-Up
- Top Alzheimer's Treatment Stocks
- Top Biotech Stocks
- Top Plant-based Food Stocks
- Biggest Cannabis Stocks
- Biggest Pharma Stocks
- Longevity Stocks to Watch
- Psychedelics Stocks to Watch
- Top Cobalt Stocks
- Small Biotech ETFs to Watch
- Top Life Science ETFs
- Biggest Pharmaceutical ETFs
- Life Science Outlook
- Biotech Outlook
- Cannabis Outlook
- Pharma Outlook
- Psychedelics Outlook
- All Market Outlook Reports
Orion Nutraceuticals Inc., (CSE:ORI) (the “Company” or “Orion”) announces that it will issue a total of 915,000 common shares of the Company at a deemed price of $0.10 per share to certain persons for certain consulting services provided to the Company owed totaling approximately $91,500.
Orion Nutraceuticals Inc., (CSE:ORI) (the “Company” or “Orion”) announces that it will issue a total of 915,000 common shares of the Company at a deemed price of $0.10 per share to certain persons for certain consulting services provided to the Company owed totaling approximately $91,500.
The shares issued pursuant to the Agreement are subject to a four month hold period.
About Orion Nutraceuticals Inc.
Orion Nutraceuticals Inc. aims to set a new standard in cannabis life science by producing and developing innovative products with key strategic partners in the industry. In conjunction with its professional sports strategic alliances, the company is poised to advance research and development in the plant science sector, deliver science-based products and services, and market CBD therapies to the mainstream with proprietary brands and products. Orion shares trade in Canada on the CSE under the symbol ORI.
ON BEHALF OF THE BOARD
Orion Nutraceuticals Inc.
www.orionnutra.ca
Investor Relations
investors@orionnutra.ca
Keep up to date with Orion on our social media channels:
Twitter: @orionnutra
Facebook: @orionnutra
Instagram: @orionnutra
LinkedIn: @orionnutra
The CSE and Information Service Provider have not reviewed and does not accept responsibility for the accuracy or adequacy of this release.
Click here to connect with Orion Nutraceuticals Inc. (CSE:ORI) for an Investor Presentation.
Source: cloud.stockwatch.com
Latest News
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.